Skip to content

Meditology Services

Healthcare-focused cybersecurity and GRC consultancy offering HITRUST, SOC 2, and HIPAA compliance assessments, backed by Primus Capital.

Visit Website ↗ + Add to Compare
57/100Incremental Innovator

Overview

Meditology Services is an Atlanta, Georgia-based cybersecurity, privacy, and regulatory compliance consultancy founded in 2011 and focused exclusively on the healthcare sector. The firm is run by former CISOs and privacy officers and staffs engagements with consultants holding credentials including CISSP, OSCP, CISA, HITRUST, and CIPP. Its service lines include security and privacy risk assessments, HITRUST and SOC 2 assurance work, PCI-DSS ASV/QSA services, HIPAA and OCR compliance support, penetration testing, and cloud security reviews, serving clients from small medical practices to large national health systems.

In February 2022, Meditology received a growth investment from Primus Capital, a private equity firm, and in November 2025 the company announced the acquisition of CORL Technologies, a third-party risk management (TPRM) specialist, expanding its portfolio into vendor risk management alongside its existing GRC and technical assessment work. The combined company operates from offices in Atlanta, Philadelphia, Denver, San Diego, and St. Louis.

Because HITRUST certification, SOC 2 attestation, and PCI QSA status are independently issued and audited credentials rather than self-reported marketing claims, Meditology’s core service portfolio comes with a built-in layer of third-party verification uncommon among general security consultancies. Its narrow healthcare focus and PE-backed growth trajectory (including the CORL acquisition) position it as a credible, if services-based rather than product-based, player in a regulatory space where HIPAA and HITRUST compliance demand is structurally durable.

Innovation Matrix Assessment

Innovation Velocity 6/10

The November 2025 acquisition of CORL Technologies to add third-party risk management shows active portfolio expansion beyond its original healthcare GRC and assessment services.

Operational Value 6/10

Delivers from five US offices with a consultant bench holding independently issued certifications (CISSP, OSCP, HITRUST, CIPP), covering assessments, HITRUST/SOC 2 assurance, PCI QSA work, and pentesting for healthcare clients ranging from small practices to national health systems.

Market Momentum 6/10

A 2022 Primus Capital growth investment followed by the 2025 CORL Technologies acquisition are concrete, independently reported growth and expansion signals.

Category Disruption 3/10

A specialized professional-services and assessment model rather than a technology product; valuable but not disruptive in the way a novel platform would be, scored accordingly.

Real-World Efficacy 6/10

HITRUST certification, SOC 2 attestation, and PCI QSA status that the firm helps clients achieve are independently audited outcomes, and trade press has named Meditology among the top security firms hospitals use.

Enduring Relevance 7/10

HIPAA, OCR, and HITRUST compliance obligations are structurally mandated for healthcare organizations, keeping specialized healthcare GRC and assessment services in persistent demand.

Why CISOs Should Care

Gives healthcare CISOs and compliance leaders access to former-CISO-led, certification-backed HITRUST/SOC 2/HIPAA assessment expertise, now extended into third-party risk management via the CORL acquisition.

What Makes It Different

Combines deep, exclusive healthcare-sector focus with credentialed consultants and independently audited compliance outcomes (HITRUST, SOC 2, PCI QSA), rather than serving as a generalist GRC consultancy.

The Matrix Verdict

57/100 — INCREMENTAL INNOVATOR

A credible, PE-backed healthcare GRC and assessment specialist with real independently verified credentials and a recent expansion into third-party risk management; strong within its niche but a services business rather than a scalable product.

Editorial Note: Claims vs. Verified Findings

The 'ranked #1 security firm hospitals use' claim originates from the company's own press release rather than an independent survey publication; HITRUST/SOC 2/PCI QSA credentials and the Primus Capital investment and CORL acquisition are independently verifiable.

Sources